Global enteral nutrition market was valued at US$ 13.11 billion in 2016, according to Global Enteral Nutrition Market, by Disease Type (Standard and Chronic), by Age Group (Below 15, 15 to 30, 30 to 45, 45 to 60, and Above 60), by End-use Industry (Hospitals, Clinics, and Long Term Care Facilities).
The enteral nutrition market is expected to register a CAGR of 4.47% over the forecast period (2017–2025), to reach US$ 19.31 billion by 2025. Some of the major factors propelling growth of this market are growing global geriatric population and rising prevalence of chronic diseases including diabetes, cardiovascular diseases, cancer, and others. According to the Centers for Disease Control and Prevention (CDC), in 2016, chronic diseases accounted for most of the deaths in U.S. and are responsible for 7 out of 10 deaths among Americans each year. In addition to this, increasing cases of premature births and malnutrition is expected to support growth of the enteral nutrition market.
According to the World Health Organization (WHO), globally, preterm birth is the leading cause of death in children under the age of 5 years and the countries including India, China, U.S., Nigeria, Pakistan, Indonesia, Brazil, Bangladesh and Philippines recorded the highest number of preterm births as of November 2017. Furthermore, increasing advancements in technology such as tubes manufactured from polyurethane or silicone coupled with the development of percutaneous endoscopic gastrostomy techniques and surge in demand for home care services are some of the other factors supporting growth of the market. According to the Agency for Clinical Innovation (ACI), approximately 9000 people received home enteral nutrition (HEN) therapy in New South Wales (NSW), in 2012.
To know the latest trends and insights prevalent in this market, click the link below:
Browse 180 market data tables* and 100 figures* on "Enteral Nutrition Market” - Global forecast to 2025.
Key Trends and Analysis of Enteral Nutrition Market:
- Among disease type, chronic was the dominant segment in 2016, and is anticipated to record the fastest growing segment over the forecast period. The segment is further segment into renal, hepatic, diabetic, and others and involves the usage of these disease specific enteral nutrition formula.
- Among age group, the market is segmented into below 15, 15 to 30, 30 to 45, 45 to 60, and above 60. Above 60 segment accounted for the largest share in the global enteral nutrition market in 2016, as chronic diseases are more prevalent in geriatric population. According to the data provided by National Council on Aging, in 2016, approximately 90% of the geriatric population suffered from least one chronic disease and nearly 75% suffer from least two. The most common chronic diseases include cancer, diabetes, heart disease, and stroke.
Key Takeaways of the Market:
- North America held the dominant position in the global enteral nutrition market in 2016, and was valued at US$ 4.24 Bn, and is projected to register a CAGR of 3.70% in terms of revenue over the forecast period. This is majorly due to the high number of premature births in the region, which is one of the key factors fuelling growth of the enteral nutrition market. Children, born before the 32nd and 34th week of gestation are required to receive a nasogastric tube for feeding right after birth. According to the data provided by the National Center for Biotechnology Information (NCBI), North America witnessed a significant rise in preterm births in 2016. Further, this incidence has recorded a significant growth in the past 25 years. In addition, according to the Centers for Disease Control and Prevention (CDC), in 2016, 1 out of every 10 infants were preterm born in the U.S. This factor is one of the key factors responsible for high growth of the enteral nutrition market in North America.
- Europe is expected to record a substantial growth in demand for enteral nutrition over the forecast period. The market is primarily driven by rising incidences of cancer and diabetes in the region. According to , in 2016, over 2.4 million people in the U.K. were affected by cancer, which is anticipated to cross 3.7 million by the end of 2035. Further, according to International Diabetes Federation, in 2015, over 6.5 million in Germany were suffering from diabetes, which is anticipated to grow at a steady rate over the forecast period. These factors are expected to aid in growth of the market.
Major players operating in the global enteral nutrition market include Nestle S.A., Baxter International Inc., B. Braun Holding GmbH & Co. KG, Abbott Laboratories, Groupe Danone, Reckitt Benckiser Group Plc , Perrigo Company Plc., Meiji Seika Pharma Co. Ltd., and Fresenius Kabi AG.